RITESH PATEL: Open Payments
NPI 1548371982 · SCHAUMBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,626 in 82 payments from 24 companies in 2025. Trend: 2023 $1,282 · 2024 $1,787 · 2025 $1,626
Food & beverage: $1,626
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $220 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $220 |
| Amgen Inc. | 11 | $204 |
| Novo Nordisk Inc | 6 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $90 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $79 |
| ABBVIE INC. | 4 | $67 |
| Lilly USA, LLC | 3 | $64 |
| Exact Sciences Corporation | 3 | $62 |
Products named: JARDIANCE, Ozempic, FARXIGA, CAPLYTA, EVENITY, XIFAXAN, AIRSUPRA, ISTURISA.
Industry payments across IL — which companies pay providers there.
